(CNN)During the global scramble to secure vaccines, many countries in Asia-Pacific were slow off the mark. This time, they re not making the same mistake. Countries around the region are rushing t.
Merck is seeking US Food and Drug Administration emergency use authorization for the drug Molnupiravir and if it s granted, the capsule will become the first oral antiviral treatment against
According to a report by drug pricing experts at the Harvard School of Public Health (HSPH) and King’s College Hospital in London, a five-day course of molnupiravir only costs $17.74 to produce. [.]